MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2023 International Congress » Parkinson's Disease: Non-Motor Symptoms

Meeting: 2023 International Congress

A comparative analysis of vegetative disorders in Parkinson`s disease and vascular parkinsonism.

R. Juraev, R. Matmurodov, K. Khalimova (Tashkent, Uzbekistan)

A comparison of national data on Parkinson’s disease mortality between the USA and UK

N. Smati, W. Lintiso, E. Shamim (Gaithersburg, USA)

Alopecia in females with young onset Parkinson’s Disease: an exploratory survey

K. Fisher, E. Clifford, N. Piniella, A. Leder, R. Gallagher (Glen Head, USA)

An objective shortened 5-item smell test: determinants of performance and agreement with subjective assessment

Z. Markovic-Obiago, J. Bestwick, H. Chohan, C. Simonet, A. Shrag, A. Noyce (London, United Kingdom)

Analysis of excessive daytime sleepiness and clinical findings in Parkinson’s disease

S. Ueno, N. Nishikawa, H. Takeshige-Amano, T. Ogawa, D. Kamiyama, A. Shindo, K. Shiina, K. Ishikawa, T. Tsunemi, M. Yoshitake, C. Abe, S. Saiki, T. Hatano, N. Hattori (Tokyo, Japan)

Angiotensin-converting enzyme inhibitors prevent pneumonia in patients with Parkinson’s disease

A. Kim, JY. Joon Yeon (Cheongju-si, Republic of Korea)

Apathy correlated with motor and non-symptoms in de-novo patients with Parkinson’s disease

S. Lee, S. Jo, J. Lee, S. Chung (Seoul, Republic of Korea)

Apomorphine effects on Parkinson’s disease fluctuation related pain: a pilot study

P. Alizadeh, V. Bruno, K. Naser, A. Abusarair, B. Achen (Calgary, Canada)

Aspects of early detection of parkinson`s disease in ambulatory settings

R. Matmurodov, B. Muminov, E. Abduqodirov, H. Daminova, K. Khalimova, O. Naimov, R. Juraev (Tashkent, Uzbekistan)

Assessing non-motor symptoms and associations with quality of life among patients in Korle-Bu Teaching Hospital, Ghana

D. Brodie-Mends, F. Duodu, K. Nkromah, A. Akpalu (Accra, Ghana)

Association between dysphagia and body mass index and his impact on the severity of anxiety in patients with Parkinson Disease

EC. Santiago, AJ. Hernández Medrano, MA. Ruiz Mafud, AA. Herrera Ruiz, DR. Aguilar Godinez, LG. Lira Juárez, MA. Medrano Delgado, AM. Regalado Mustafá, A. Domínguez García, G. Hernandez Armesto, DP. Romero Terán, K. Talavera Lagunas, MF. Medina-Pérez, JF. García Hernández, A. Abundes-Corona, GI. Cerda Hernández, M. Rodríguez-Violante, A. Cervantes-Arriaga (MÉXICO, Mexico)

Association between Parkinson’s Disease and Atrial Fibrillation: A Literature Review

W. Lintiso, N. Smati, E. Shamim (Gaithersburg, USA)

Association between supine hypertension and plasma free triiodothyronine in drug-naïve Parkinson’s disease

T. Umehara, T. Kokubu, J. Takahashi, T. Shiraishi, T. Sato, A. Onda, I. Iguchi (Tokyo, Japan)

Association between type 2 diabetes mellitus with parkinson’s disease and the increase of the severity of depression and anxiety in a mexican population

AA. Herrera Ruiz, DR. Aguila Godinez, AJ. Hernández-Medrano, MA. Ruiz Mafud, A. Abundes-Corona, A. Cervantes-Arriaga, M. Rodríguez-Violante (Mexico City, Mexico)

Association of vestibular disorders with autonomic dysfunction in Parkinson’s Disease

O. Alenikova, M. Leshkovich (Minsk, Belarus)

Associations between non-motor symptoms and patient characteristics in Parkinson’s disease: A multicenter cross-sectional study

R. Morimoto, M. Iijima, Y. Okuma, K. Suzuki, F. Yoshii, S. Nogawa, T. Osada, K. Kitagawa (Tokyo, Japan)

Bowel symptoms and management practices in Parkinson’s disease and related conditions: results from the PRIME-UK study.

C. Thomas, E. Tenison, K. Lloyd, M. Smith, Y. Ben-Shlomo, E. Henderson (Gloucestershire, United Kingdom)

Cardiovascular complications in Parkinsonism: insights from Luxembourg Parkinson’s Study

S. Acharya, A. Lumley, Y. Devaux (Strassen, Luxembourg)

Characteristics of Pain in Parkinson’s Disease with Arabic translation and validation of King’s Parkinson’s Disease Pain Scale

T. Roushdy, E. Hamid, H. Salem, S. Reda, A. Shalash (cairo, Egypt)

Characterization of at-home sleep macrostructure in Parkinson disease using a wearable sleep monitoring device

J. Thompson, L. Hirt, D. Kern, A. Baumgartner (AURORA, USA)

Chronic pain and the polytrauma clinical triad are risk factors for prodromal PD

L. Neilson, N. Balba, J. Elliott, G. Scott, M. Heinricher, M. Lim (Portland, USA)

Cognitive function in Parkinson’s disease: associations with perivascular space in basal ganglia

L. Luo, L. Li, Y. Yin, R. Ren, Y. Yang (Kunming, China)

Common oscillatory patterns between Parkinson’s disease and heroin dependent patients: a resting-state EEG study

D. Benis, V. Fleury, P. Krack (Geneva, Switzerland)

Comparison of original and revised versions of the University of Pennsylvania Smell Identification Test

M. Brumm, K. Pierz, W. Aamodt, C. Gochanour, R. Kurth, C. Coffey, T. Foroud, E. Brown, R. Doty, T. Simuni, C. Tanner, K. Marek, A. Siderowf (Iowa City, USA)

Compliance with national and international guidelines in the treatment of non-motor symptoms in late stage Parkinson’s disease

K. Rosqvist, P. Odin (Lund, Sweden)

Constipation in Parkinson’s disease, a common problem with rare but serious complications

S. Lopes, S. Marques, A. Ferreira, S. Varanda, AM. Rodrigues (Braga, Portugal)

Correlates of gait impairment in parkinson’s disease

E. Abdeldayem, A. Shalash (Cairo, Egypt)

Correlation between dose of dopamine replacement therapy and King’s Parkinson’s Disease Pain Scale in Mexican Patients with Parkinson’s Disease

A. Regalado Mustafá, D. Aguila Godinez, A. Herrera Ruiz, E. Santiago-de-La-Cruz, L. Lira Juárez, M. Medrano Delgado, M. Ruiz Mafud, A. Hernández-Medrano, D. Romero-Terán, M. Medina-Pérez, G. Cerda Hernández, M. Rodríguez-Violante, A. Cervantes-Arriaga, G. Hernandez Armesto, A. Abundes-Corona, A. Domínguez García, J. García Hernández, A. Alcocer Salas, K. Talavera Lagunas (Mexico City, Mexico)

Correlation between fatigue, sleep dysfunction and health-related quality of life in Parkinson’s disease patients

EL. Ungureanu, S. Berzunțeanu, ș. Diaconu, A. Zârnoveanu, T. Drăgan, B. Ciocănescu, R. Filip, N. Enache, C. Falup-Pecurariu (Brasov, Romania)

Cortical excitability of sensorimotor cortex in Parkinson’s disease-related pain

MK. Lu, CM. Chen, SM. Liu, CH. Tsai (Taichung, Taiwan)

Defining neuropsychiatric symptoms fluctuations in Parkinson’s disease

A. Trinchillo, FP. Cucinotta, A. de Angelis, I. Cociasu, M. Horne, F. Morgante, L. Ricciardi (Giugliano in Campania, Italy)

Depression and Activities of Daily Living in Idiopathic Parkinson’s Disease without Dementia.

L. Ortega, C. González, S. Otalvaro, J. Ayala (Cali, Colombia)

Determinants of quality of life and daily mobility in Parkinson’s disease: the role of fear of falling.

A. Magliozzi, V. Pozzilli, G. Sergi, V. Di Lazzaro, M. Marano (Roma, Italy)

Development and preliminary results of a new picture-based self-rating tool for neuropsychiatric syndromes in Parkinson’s disease

S. Simon, JC. Baldermann, K. Böttcher, S. Meißner, C. Schedlich-Teufer, D. Gruber, D. Podes, LS. Neumaier, E. Kalbe, GR. Fink, G. Ebersbach, W. Jost, M. Barbe, J. Kessler, ST. Jost (Cologne, Germany)

Differences in patients with Impulse Control Disorder based on antiparkinsonian drug treatment in a Mexican Institute.

LG. Lira Juárez, AJ. Hernández-Medrano, MF. Medina Pérez, DP. Romero-Terán, MA. Ruiz Mafud, MAG. Medrano Delgado, AY. Regalado Mustafá, K. Talavera Lagunas, EC. Santiago Delacruz, G. Hernandez Armesto, DR. Aguila Godinez, AA. Herrera Ruiz, GI. Cerda Hernández, A. Abundes-Corona, A. Cervantes-Arriaga, M. Rodríguez-Violante, A. Alcocer Salas, JF. García Hernandez, A. Domínguez García (Mexico, Mexico)

Diplopia (Double vision) in Parkinson’s disease patients: prevalence and nonmotor effect

EL. Ungureanu, KR. Chaudhuri, ș. Diaconu, L. Irincu, R. Filip, B. Ciopleiaș, C. Falup-Pecurariu (Brasov, Romania)

Distinct striatal connectivity patterns in patients with Parkinson’s disease with and without urinary symptoms

N. Piramide, R. de Micco, F. Di Nardo, M. Siciliano, G. Caiazzo, G. Tedeschi, F. Esposito, A. Tessitore (Napoli, Italy)

Dopamine dysregulation syndrome in Parkinson’s disease controlled by safinamine

SK. Song, JH. Kang (Jeju-Si, Republic of Korea)

Drivers of Health-Related Quality of Life in Parkinson’s Disease: non-motor symptoms and time spent in daily activities

C. Painous, I. Pijuan, E. Tolosa (Barcelona, Catalonia)

Drooling is associated with disease severity in Parkinson’s disease

N. Nishikawa, E. Ikami, H. Takeshige, T. Ogawa, T. Hatano, N. Hattori (Tokyo, Japan)

Dynamic assessment of levels of depression and anxiety impairment in Parkinson’s disease

O. Naimov, R. Matmurodov (Tashkent, Uzbekistan)

Dysphagia in Parkinson’s disease

M. Carmona-Abellan, A. Ibargutxi, E. Gómez, N. Zuza, B. Díez-Arrola, K. Berganzo, C. Garcia-Monco, J. Zabala, A. Bilbao, U. Pequeño (Bilbao, Spain)

Effect of deep brain stimulation on dysphagia in Parkinson’s disease: A Systematic Review

A. Rossato, L. Aires, L. Lobato, V. Müller, H. Rodrigues, C. Menegon, V. de Souza, G. Maia, L. Fernandez (Porto Alegre, Brazil)

Effects of Eromomastax speciosa in a Gastric Ulcer in a 6-hydroxydopamine (6-OHDA)-induced Rat Model of Parkinson’s Disease.

GL. Ndji Otto, P. Amang, H. Adjia (Bertoua, Cameroon)

Effects of Motor Subtype Stability on Non-Motor Symptoms in Early Parkinson’s Disease

S. Ng, N. Chia, X. Choi, D. Heng, S. Neo, ZY. Xu, KY. Tay, WL. Au, EK. Tan, L. Tan (Singapore, Singapore)

Efficacy of melatonin in patients with insomnia and Parkinson’s disease

A. Domínguez-García, DR. Aguila-Godinez, AA. Herrera-Ruiz, EC. Santiago-Delacruz, LG. Lira-Juárez, MAG. Medrano-Delgado, MA. Ruiz-Mafud, AJ. Hernández-Medrano, AY. Regalado-Mustafá, DP. Romero-Terán, MF. Medina-Pérez, GI. Cerda-Hernández, M. Rodríguez-Violante, A. Cervantes-Arriaga, G. Hernandez-Armesto, A. Abundes-Corona, A. Alcocer-Salas, K. Talavera-Lagunas (CDMX, Mexico)

Exploring brain mechanisms of identity attribution in presence hallucinations of Parkinsonian origin

J. Potheegadoo, N. Vehar, F. Bernasconi, C. Stucker, S. Stampacchia, O. Blanke (Geneva, Switzerland)

First approach of a sensor-based assessment of the camptocormia angle

K. Knutzen, K. Naderi Beni, R. Wolke, J. Kuhtz-Buschbeck, R. Rieger, NG. Margraf (Kiel, Germany)

Fluorescence-lifetime ophthalmoscopy findings in Parkinson’s disease patients with visual disturbances

K. Shivok, E. Affel, M. Alizadeh, T-W. Liang, D. Kremens, R. Sergott (Philadelphia, USA)

Gender differences in non-motor fluctuations in Parkinson’s disease

G. Donzuso, C. Cicero, E. Vinciguerra, R. Sergi, A. Luca, G. Mostile, C. Terravecchia, M. Zappia, A. Nicoletti (Catania, Italy)

gender differences of fatigue and sleep characteristics in parkinson’s disease patients

S. Diaconu, S. Berzunteanu, E. Ungureanu, B. Ciopleias, R. Zosin, M. Cusnir, A. Iacob, I. Murasan, B. Ciocanescu, C. Falup-Pecurariu (Brasov, Romania)

Gender-Specific Classification Models for Parkinson’s Disease using Non-Motor Symptoms and DNA Methylation Data

MZA. Ali, PSD. Dholaniya (Hyderabad, India)

Genetic and psychiatric risk factors for impulse control disorders in de novo Parkinson’s disease

M. Ruitenberg, E. Whooley, H. Macdonald, V. Koppelmans (Leiden, Netherlands)

Gut dysbiosis in Indian Parkinson’s Disease Patients with Constipation

S. Pavan, M. Ballal, A. Prabhu, B. Das, A. Mutreja, K. Vasudevan (Manipal, India)

Gut microbiota dysbiosis in Parkinson’s disease patients: a potential biomarker of disease severity and progression?

R. Cerroni, M. Conti, M. Pierantozzi, V. D'Angelo, N. Mercuri, A. Teofani, D. Pietrucci, G. Chillemi, V. Unida, A. Stefani (Rome, Italy)

Hearing impairment and non-motor symptoms in Parkinson’s disease: association and impact on quality of life

E. Garasto, M. Conti, A. Viziano, A. Stefani, M. Pierantozzi, NB. Mercuri, A. Moleti, R. Sisto, T. Schirinzi, R. Cerroni (Rome, Italy)

Hospital based motor cognitive rehabilitation training. what after? An intervention aimed at patients support between admissions

C. Siri, A. Carollo, G. Manoni, M. Canesi (Milano, Italy)

Identifying prodromal NMS in a population-based recruitment strategy: Kassel data of Healthy Brain Ageing

S. Schade, C. Vega Moreno, C. Horlings, A. Garrido, T. Marques, P. Mahlknecht, E. Bryan, C. Gomes, C. Pauly, S. Ghosh, K. Rege, R. Rawal, T. Wicke, E. Lang, S. Schnell, V. Satagopam, K. Seppi, M. Marti, E. Tolosa, W. Poewe, R. Krüger, C. Trenkwalder, B. Mollenhauer (Kassel, Germany)

Impact of deep brain stimulation of the subthalamic nuclei on non-motor symptoms in Parkinson’s disease: a monocentric prospective study with a 12-month follow-up

V. Leclercq, V. Donckels, E. Hanon, S. Dethy (Sint-Pieters-Leeuw, Belgium)

Impact of dopamine replacement therapy on shame in Parkinson’s disease patients

S. Catalano Chiuvé, D. Benis, A. Zulet, P. Krack, V. Fleury (Geneva, Switzerland)

Impact of non-motor fluctuations on QOL in patients with Parkinson’s disease

A. Kakimoto, M. Kawazoe, K. Kurihara, T. Mishima, Y. Tuboi (Fukuoka, Japan)

Impact of vitamin supplements intake on non-motor fluctuations measured by (NoMoFA) in people living with Parkinson’s disease.

M. Ruiz Mafud, A. Hernández Medrano, D. Aguila Godinez, A. Herrera Ruiz, D. Romero Teran, M. Medrano Delgado, M. Rodriguez Violante, A. Cervantes Arriaga, L. Lira Juarez, A. Abundes Corona, G. Hernandez Armesto, E. Santiago Cruz, A. Dominguez Garcia, A. Regalado Mustafá, G. Cerda Hernandez, K. Talavera Lagunas (Cuidad de México, Mexico)

Improvement of short-term satisfaction with life and treatment in Parkinson´s disease after subthalamic stimulation

A. Sauerbier, P. Bachon, L. Ambrosio, P. Loehrer, A. Rizos, S. Jost, A. Gronostay, G. Fink, K. Ashkan, C. Nimsky, V. Visser-Vandewalle, K. Ray Chaudhuri, L. Timmermann, P. Martinez-Martin, H. Dafsari (Köln, Germany)

Impulse Control Disorder and medication management in Patients with Early-Onset Parkinson’s Disease

J. Jacobson, K. Ghoniem, A. Mullan, P. Turcano, C. Stang, E. Camerucci, C. Piat, J. Bower, R. Savica (Rochester, USA)

Incidence of orthostatic hypotension in Parkinson´s disease patients starting antiparkinsonian treatment

C. Borrue, P. Couto (San Sebastian delosReyes, Spain)

Investigating Digital Biomarkers in Parkinson’s Disease

C. Louis, R. Shon, E. Shah, S. Isfahani (Fullerton, USA)

Is a Parkinson’s Sialorrhoea service effective?

C. Williams, J. Adenwalla, B. Mohamed, C. Marquis, C. Thomas, R. Lewis-Morton (cardiff, United Kingdom)

Left hemisphere theta coherence between cortex and STN increases during speech

A. Nakhmani, R. Smith, V. Del Bene, M. Nelson, J. Olson, S. Brinkerhoff, Z. Irwin, J. Bentley, R. Knight, H. Walker (Birmingham, USA)

Levodopa-induced orthostatic hypotension in a large cohort of patients with Parkinson’s disease undergoing an acute levodopa challenge test

X. Wang, S. Mei, C. Han, P. Chan (Beijing, China)

Longitudinal follow-up of pure autonomic failure with cardiac sympathetic denervation: Relevance to the body-first theory of Parkinson’s disease

T. Fay Karmon, S. Hassin-Baer, Z. Shabtai, E. Druker, A. Leibowitz, Y. Sharabi (Petach Tikva, Israel)

Machine Learning Model for Prediction of acute orthostatic hypotension after levodopa administration

Z. Liu, SN. Lin, ZL. Chen, Y. Ling, T. Feng (Beijing, China)

Management of constipation in Parkinson’s patients presenting with acute sigmoid volvulus to Royal Berkshire Hospital,Reading, UK

M. Khwaja, S. Alam, E. Castaneda-Caicedo, A. Chatterjee (Reading, United Kingdom)

Management of Sigmoid Volvulus in Parkinson’s patients presenting to Royal Berkshire Hospital, Reading ,UK.

M. Khwaja, S. Alam, A. Chatterjee, E. Castaneda-Cicedo (Reading, United Kingdom)

Microbiota and Gastrointestinal Manifestations of Parkinson’s Disease with Arabic Translation of Gastrointestinal Dysfunction Scale

Y. Salah, N. Dawood, M. Salama, A. Shalash (cairo, Egypt)

motor and non-motor correlates of hyposmia detected by the italian olfactory identification test (ioit) in an italian cohort of parkinson’s disease patients

A. Mechelli, N. Tambasco, M. Filidei, C. Maremmani, M. Pierini, P. Nigro, S. Simoni, L. Parnetti (Catanzaro, Italy)

Needs and priorities of people with Parkinson’s and care partners regarding neuropsychiatric symptoms

J. Goldman, H. Peirce, D. Merkitch (Chicago, USA)

Neurogenic orthostatic hypotension is not associated with generalized dysautonomia in early motor PD

J. Li, J. Ruiz Tejeda, D. Tran, S. Nguyen, N. Phielipp (Irvine, USA)

Neurologic dysfunction assessment in Parkinson’s disease based on fundus photographs using deep learning

S. Ahn, J. Shin, SJ. Song, WT. Yoon (Suwon, Republic of Korea)

Nocturnal behavior of people with Parkinson’s disease

C. Duval, A. Karelis, J. Daneault (Montreal, Canada)

Non-motor symptoms of Parkinson’s disease: an analysis of gender and age-related differences in a large online cohort

D. Teixeira-Dos-Santos, G. Pereira, C. Rieder, A. Schumacher-Schuh (Porto Alegre, Brazil)

Non-motor Symptoms Progression in Parkinson´s Disease. A 4-year Follow-up Study.

D. Santos, T. de Deus, C. Cores, M. Feal Painceiras, I. García-Díaz, M. íñiguez, J. Paz González, S. Jesús, M. Cosgaya, J. García Caldentey, N. Caballol, I. Legarda, J. Hernández Vara, I. Cabo, L. López Manzanares, I. González Aramburu, M. Avila, V. Gómez Mayordomo, V. Nogueira, J. Dotor, C. Borrué, B. Solano, M. álvarez Sauco, L. Vela, S. Escalante, E. Cubo, Z. Mendoza, J. Martínez Castrillo, P. Sánchez Alonso, M. Alonso Losada, N. López Ariztegui, I. Gastón, J. Kulisevsky, M. Seijo, C. Valero, R. Alonso Redondo, M. Buongiorno, C. Ordás, P. Martínez Martín, P. Mir, C. Coppadis (A Coruña, Spain)

Novel digital marker detects minor hallucinations online at home of patients with Parkinson’s disease

L. Albert, F. Bernasconi, J. Potheegadoo, B. Herbelin, O. Blanke (Geneva, Switzerland)

Obsessive-Compulsive symptoms in Parkinson’s Disease: beyond the Impulse Control Disorders

D. Damas, M. Fernandes, I. Carvalho, C. Fernandes, A. Araújo, I. Cunha, J. Lemos, F. Moreira (Coimbra, Portugal)

Oculomotor changes in the premotor stage of LRRK2- G2019S associated Parkinson’s disease.

M. Rivera Sánchez, C. Lage Martínez, A. Sánchez Rodríguez, M. Sierra Peña, I. González Aramburu, L. Manrique Arregui, MV. Sánchez Peláez, C. García Cena, A. Calvo Córdoba, J. Madera Fernández, J. Martín Arroyo, J. Infante Ceberio (Santander, Spain)

Olfactory and taste function in early Parkinson’s disease with mild cognitive impairment

JJ. Lee, IH. Kwak, HI. Ma, YE. Kim (Anyang-si, Republic of Korea)

Olfactory discrimination differentiate drug-induced parkinsonism and Parkinson’s disease

IH. Kwak, JJ. Lee, MS. Kim, SY. Kang, HI. Ma, YE. Kim (Anyang-si, Republic of Korea)

Olfactory sniffing is altered in patients with Parkinson’s disease

M. Andelman-Gur, N. Hezi, A. Ezra, J. Zitser, T. Gurevich, N. Sobel (Rehovot, Israel)

ON/OFF Non-Motor Evaluation: A New Way to Evaluate Non-Motor Fluctuations in Parkinson’s Disease

F. Faggianelli, T. Witjas, JP. Azulay, I. Benatru, C. Hubsch-Bonneaud, M. Anheim, C. Moreau, E. Hainque, S. Drapier, B. Jarraya, C. Laurencin, D. Guehl, L. Hopes, C. Brefel-Courbon, M. Tir, A. Marques, T. Rouaud, D. Maltête, C. Giordana, K. Baumstarck, O. Rascol, JC. Corvol, AS. Rolland, D. Devos, A. Eusebio (Marseille, France)

Orthostatic hypotension and frailty

A. Ovchynnykova, E. Trufanov (Kyiv, Ukraine)

Pain and moods disorders as determinants of quality of life in Parkinson

D. Ortiz-Zacarias, I. Estrada-Bellmann, R. Estrella-Silva, J. Trejo-Ayala (Monterrey, Mexico)

Pain and sleep in Parkinson’s disease

A. Zarnoveanu, S. Diaconu, B. Ciopleias, L. Ungureanu, T. Dragan, B. Ciocanescu, T. Moldovan, C. Falup-Pecurariu (Brasov, Romania)

Pain Phenomenon in Parkinson Disease

R. Pinzon (Yogyakarta, Indonesia)

PDQ-39 predicts quality of life improvement following neurostimulation for Parkinson’s disease: Prospective observational study

L. Torrão, M. Rosas, J. Massano, A. Oliveira, C. Chamadoira, M. Rito, J. Guimarães, C. Soares (Póvoa de Varzim, Portugal)

Physical exercise as a promising option for treating fatigue in Parkinson’s disease? Results of a systematic review and meta-analysis of non-pharmacological interventions

A. Folkerts, J. Nielsen, R. Gollan, A. Lansu, D. Solfronk, I. Monsef, N. Skoetz, K. Zeuner, E. Kalbe (Cologne, Germany)

Polyneuropathy in Parkinson’s disease: cross-sectional analysis of the Bochum Parkinson Nerve Study cohort

R. Scherbaum, L. Basner, L. Ortmann, J. Steininger, K. Müller, A. Bieber, P. Schülken, J. Motte, A. Fisse, T. Grüter, R. Gold, K. Pitarokoili, L. Tönges (Bochum, Germany)

Prevalence and severity of non-motor symptoms in hispanic at-risk population with REM-sleep behavior disorder.

E. Argüelles-González, A. Jorge-de Sarachaga, R. Solís-Vivanco, A. Abundes-Corona, A. Cervantes-Arriaga, M. Rodríguez-Violante (Mexico City, Mexico)

Probiotics for treatment of constipation in Parkinson’s patients: a systematic review and meta-analysis

M. Alsaied, A. Elettreby, A. Abo Elnaga, D. Kamal, G. Alderbi, A. Sharkawy, R. Fareed (Mansoura, Egypt)

Psychometric properties of the Neuropsychiatric Fluctuations Scale: preliminary results in patients with Parkinson’s disease

C. Rodriguez-Blazquez, I. Debove, S. Murcia, A. Zenger, MM. Kurtis, E. Cubo, C. Falup-Pecurariu, KR. Chaudhuri, H. Reichmann, B. Falkenburger, S. Bostantjopoulou, P. Martinez-Martin, MJ. Forjaz, M. Bereau, P. Krack (Madrid, Spain)

Pupil response is impaired in clinically isolated REM Sleep Behavior Disorder and Parkinsons’ Disease

W. Hermann, M. Brandt, T. Sehr, U. Walter, H. Reichmann, A. Storch, T. Ziemssen (Rostock, Germany)

Quantitative Evaluation of Seborrheic Dermatitis in Patients with Autonomic Dysfunction.

R. Sengoku, A. Nakahara, T. Kitagawa, M. Ikeda, H. Matsuno (Tokyo, Japan)

Ramelteon ameliorates abnormal sleep-wake behavior in a zebrafish model of Parkinson’s disease by facilitating abnormal lipid metabolism

F. Wang, MZ. Pang, JY. Liu, CF. Liu (Suzhou, China)

Recommendations to tackle under-recognition and under-treatment of sialorrhea in Parkinson’s Disease: Is it time for a paradigm shift?

B. Bergmans, V. Clark, S. Isaacson, T. Bäumer (Bruges, Belgium)

Regional Pain Syndromes- A potential clinical biomarker of Prodromal Parkinson’s Disease

M. Kumar (Kharagpur, India)

Risk factors for Freezing of Gait in Parkinson’s Disease: A Systematic Review and Meta-analysis

X. Zheng, J. Liu, S. Wang, R. Ou, C. Li, H. Shang (Chengdu, China)

Risk factors of sleep disordered breathing in Veterans with Parkinson’s disease.

A. Sarwar (PEARLAND, USA)

Serum Zinc Deficiency could be associated with dementia conversion in Parkinson’s disease

W. Jang (Gangneung, Republic of Korea)

Sex-specific speech correlates of dysphagia in Parkinson’s disease

JH. Ahn, D. Shin, MK. Suh, YE. Huh, J. Youn, JW. Cho, JS. Lee (Seoul, Republic of Korea)

Sexual health and sleep quality in women living with Parkinson’s disease: are we neglecting that?

KCN. Nobrega, TSM. Martins, GFS. Santos, MEP. Piemonte (Sao Paulo, Brazil)

Signs of Respiratory Dysfunction across Parkinson’s Disease Spectrum

J. Janssen Daalen, P. Ainslie, H. van Hees, M. Meinders, D. Thijsse, B. Bloem (Nijmegen, Netherlands)

Sleep disorders and their relationship to non-motor symptoms in Mexican Parkinson’s disease patients

D. Aguila-Godinez, A. Herrera Ruiz, E. Santiago, L. Lira Juarez, MA. Medrano Delgado, M. Ruiz Mafud, A. Hernandez-Medrano, A. Regalado Mustafa, G. Cerda Hernandez, M. Rodriguez-Violante, A. Cervantes-Arriaga, G. Hernandez Armesto, A. Abundes-Corona, A. Dominguez Garcia, D. Romero-Teran, K. Talvera-Lagunas, M. Medina Perez (Mexico City, Mexico)

Sleep disorders in Parkinson’s disease patients. A case-control study.

L. Rotaru, M. Cebuc, A. Lupușor, O. Grosu, S. Odobescu, O. Gavriliuc, I. Moldovanu (Chisinau, Republic of Moldova)

Sleep hygiene practice in patients with Parkinson’s disease

JY. Yun, CY. Lee, D. Kim, JH. Kim (Seoul, Republic of Korea)

Sleep quality in GBA, LRRK2 and idiopathic Parkinson disease

A. Yoo, R. Ortega, D. Raymond, B. Plitnick, M. Markgraf, J. Liang, M. Rawal, A. Wise, M. Pullman, K. Leaver, V. Katsnelson, J. Miravite, V. Shanker, M. Swan, M. Figueiro, S. Bressman, R. Saunders-Pullman (New York, USA)

Sleep seasonality in alpha-synucleinopathies: a comparative study with non-neurological sleep disorder patients

P. Bugalho, B. Meira, M. Magriço (Lisboa, Portugal)

Subtyping Parkinson’s disease: Quality of life changes after subthalamic stimulation depend on nonmotor and motor symptoms

L. Braun, S. Jost, P. Loehrer, A. Sauerbier, K. Ashkan, A. Rizos, M. Santos Ghilardi, A. Gronostay, J. Evans, M. Silverdale, R. Cury, E. Fonoff, G. Fink, A. Antonini, C. Nimsky, K. Chaudhuri, L. Timmermann, V. Visser-Vandewalle, P. Martinez-Martin, H. Dafsari (Cologne, Germany)

Supine hypertension is longitudinally associated with cognitive decline in Parkinson disease independent of orthostatic hypotension

C. Miller-Patterson, J. Hsu, M. Barrett, L. Cloud, T. Chelimsky (Richmond, USA)

Sympathetic tone abnormalities in subjects at risk for Parkinson’s Disease without evidence of nigrostriatal neurodegeneration: a multimodal biomarker study

M. Gregorio, H. Maghzi, G. Obialisi, E. Hogg, C. Malatt, E. Tan, H. Pomeroy, R. Artal, M. Shehata, B. Renner, P. Sati, G. Pagano, M. Tagliati (Los Angeles, USA)

The characterization of Parkinson’s disease related nociplastic pain based on the classification system

T. Tezuka, T. Nukariya, S. Okusa, Y. Nihei, J. Nakahara, M. Seki (Tokyo, Japan)

The effect of peptic ulcer disease on Parkinson’s disease

T. Abali, AV. Karacan, S. Kibrit, MK. Yekedüz, EY. Unutmaz, T. Eminoglu, R. Yilmaz, MC. Akbostancı (Ankara, Turkey)

The Impact of Diabetes Mellitus on Motor and Non-Motor Symptoms of Parkinson’s Disease: A Cross-Sectional Study.

IC. Rodriguez-Gonzalez, F. Botello-Villagrana, SR. Gomez-Villalobos, A. Gonzalez-Cantu, X. Torres-Mancilla, M. Gonzalez-Gonzalez, D. Martinez-Ramirez (Monterrey, Mexico)

The impact of mild cognitive impairment on functioning in people with Parkinson’s disease

J. Petrillo, TM. Brown, K. Paumier, J. Dine, R. Sawant, S. Baradaran, A. Koenig (Cambridge, USA)

The impact of wearing ‘OFF’ (WO) episodes on non-motor symptoms (NMS) burden and quality of life (QoL) in Parkinson’s disease (PD) patients

P. Nasuti, A. Brailean, W. Ali, A. Gillespie, C. Vandeloo, M. Biagioni (Brussels, Belgium)

The incidence of Parkinson’s disease in Nigeria: a systematic review and meta-analysis

A. Memudu, E. Ekhoye (Iyamho, Nigeria)

The prevalence of delirium and subsequent outcomes in inpatients with Parkinson’s disease

F. Gerakios, G. Bate, L. Wright, D. Davis, B. Stephan, L. Robinson, C. Brayne, L. Barnes, G. Stebbins, JP. Taylor, D. Burn, L. Allan, A. Yarnall, S. Richardson, R. Lawson (Newcastle Upon Tyne, United Kingdom)

The role of structural changes in the retina and the vertical vestibulo-ocular reflex abnormality in gait disorders in Parkinson`s disease

O. Alenikova, O. Davydova, N. Alenikov (Minsk, Belarus)

The significance of myocardial infarction as a developmental factor in parkinsonism and vascular parkinsonism

DT. Akramova, GS. Rakhimbaeva (Tashkent, Uzbekistan)

Trends in the evaluation and management of constipation in patients with Parkinson disease

L. Deuel, W. Wright, E. Houston (Burlington, USA)

Unveiling the Link between Stress-Related Disorders and Dysautonomic Symptoms in Parkinson’s Disease: A Cross-Sectional Study

EJ. Acosta-Espinoza, IA. Ortiz-Marroquin, DI. Salinas-Leal, A. Salinas-Blancas, HM. Macias-Cruz, D. Martinez-Ramirez (Monterrey, Mexico)

Vagus nerve degeneration in Parkinson’s disease: correlation with autonomic symptoms and pupillography

M. Batchakaschvili, M. Löhle, HR. Kleinlein, W. Hermann, H. Walter, A. Storch, U. Walter (Rostock, Germany)

Validation of the Japanese version of the King’s Parkinson’s Disease Pain Scale and the King’s Parkinson’s Disease Pain Questionnaire

K. Kurihara, S. Zfujioka, T. Mishima, Y. Tsuboi (Fukuoka, Japan)

Ventral tegmental deep brain stimulation does not influence risk-taking behaviour in a standard gambling task

S. Hirschbichler, S. Lagrata, M. Matharu, S. Manohar (St. Pölten, Austria)

White matter hyperintensities associated with impulse control disorders in Parkinson’s disease

G. Hernadi, G. Perlaki, M. Kovacs, D. David, G. Orsi, J. Janszky, N. Kovacs (Pécs, Hungary)

« View all sessions from the 2023 International Congress.

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Patients with Essential Tremor Live Longer than their Relatives
  • Life expectancy with and without Parkinson’s disease in the general population
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley